Research and Markets (http://www.researchandmarkets.com/research/5l8hsq/mild) has announced the addition of the "Mild Pain-Pipeline Insights, 2015" subscription to their offering.
This Mild Pain Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Mild Pain.
This report provides information on the therapeutic development based on the Mild Pain dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Mild Pain Overview
- Mild Pain Pipeline Therapeutics
- Mild Pain Therapeutics under Development by Companies
- Mild Pain Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Mild Pain Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Mild Pain Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Mild Pain Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Mild Pain - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Mild Pain - Discontinued Products
- Mild Pain - Dormant Products
- Companies Involved in Therapeutics Development for Mild Pain
- Appendix
For more information visit http://www.researchandmarkets.com/research/5l8hsq/mild